Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by kuatoliveson Feb 01, 2018 6:04pm
94 Views
Post# 27484470

RE:RE:RE: Share Consolidations Usually Destroy Market Capitalizati

RE:RE:RE: Share Consolidations Usually Destroy Market CapitalizatiReverse splits don't inherently destroy market capitaliziation values.  Market cap is determined by assets and revenues, not the actual price of a share. The actual price of a share is quite irrelavant. People usually associate the two because reverse splits accompany a decrease in market cap if too many shares were initially offered at too low a price. In the end, ONC, like any other company, will have its market cap determined by its revenue and pipe development. The reverse split is a non-event; however, now that ONC has begun to monetize its pipeline, a move back to the Nasdaq/TSX is probably warranted. Gotta put on the big boy pants sooner or later.

 

Bullboard Posts